The Hidden Costs Behind Trump’s Healthcare Deals
Summary
This episode of The Art of the Scam critiques the Trump administration's pharmaceutical deals, arguing that "TrumpRx" prices often exceed international averages and that key agreement details are intentionally redacted. It highlights Robert F. Kennedy Jr.'s financial conflicts of interest, including book advances and consulting fees from organizations soliciting corporate sponsorships for health summits. The segment also examines the administration's use of AI to cancel over 760,000 Affordable Care Act enrollments and the potential for algorithmic bias in denying patient care.
Topics discussed
Sponsor: Uber PIN Verification and Instagram Teen Accounts
Introduction: The Art of the Scam and Trump's Drug Claims
Trump's Impossible Claims of 400-600% Drug Price Cuts
KFF Study: Trump Rx Prices vs. International Averages
Case Study: Enbrel Cost Comparison and Blackout Details
Redacted Agreements with Pfizer and Eli Lilly
Senate Democrats Demand Disclosure of Drug Deals
Robert F. Kennedy Jr.'s Financial Conflicts of Interest
Ethics Violations and the 'Follow the Money' Argument
Sponsor: Uber PIN Verification
Mehmet Oz, CMS, and Cancellation of ACA Enrollments
Oz's Use of AI for Fraud Detection and Cost Inflation
Algorithmic Bias in Healthcare and United Health Lawsuit
Outro and Sponsor: Uber PIN Verification
Sponsor: Blinds.com Custom Window Treatments
Listen ad-free on Castria